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Examining the significance of human rights
considerations in the protection of
pharmaceutical patents
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This article discusses the human right to health in the context of patent
protection and access to medicines. It considers the limitations in international
human rights law, especially in relation to socioeconomic rights, that make it
difficult for the right to health to be a potent justification for derogation from
trade or intellectual property agreements. It concludes by taking the view that
while the right to health may be somewhat unenforceable in international law,
its close association with enforceable rights such as the right to life can be a
legitimate basis for making maximum use of the flexibilities in the international
intellectual property regime to protect public health. The article takes the view
that trade and intellectual property agreements must be interpreted in a way
that endeavours as much as possible to resolve any seeming inconsistency
with the right to health.
INTRODUCTION
The conflict between intellectual property (IP) and access to medicines has been an issue of
international concern since the emergence of the Agreement on Trade Related Aspects of Intellectual
Property Rights (TRIPS), following the conclusion of the General Agreement on Tariffs and Trade
(GATT) Uruguay Round in 1994. It seems that the primary objective to bring IP rights protection
within the World Trade Organization (WTO) framework was not to make it more consistent with
international trade rules but to strengthen and harmonise the protection of IP on a global scale as a
result of the growing concerns of the most economically advanced and industrialised nations about
losing technological leadership to newly industrialising countries in Asia and Latin America through
their free-riding activities.1 In response to the global outcry for more flexible standards in the interest
of public health, the TRIPS Council adopted the Doha Declaration on the TRIPS Agreement and
Public Health in 2001, paragraph 4 of which affirmed the “right of WTO Members to use, to the full,
the provisions in the TRIPS Agreement, which provide flexibility for this purpose” being “to protect
public health and, in particular, promote access to medicines for all” and the Implementation Decision
on Paragraph 6 of the Doha Declaration in 2003 to address this issue.2 The basic purport of the Doha
Declaration and Implementation Decision seems to be to empower countries with little or no
pharmaceutical manufacturing capacity to import essential drugs through compulsory licensing.3
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1 See Drahos P and Braithwaite J, Information Feudalism: Who Owns the Knowledge Economy? (The New Press, New York,
2002) pp 61-73.
2 See Roumet R, “Access to Patented Anti-HIV/AIDS Medicines: The South African Experience” [2010] European Intellectual
Property Review 137.
3 See Council for Trade-Related Aspects of Intellectual Property Rights, Annual Review of the Decision on the Implementation
of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, WTO Doc IP/C/57 (10 December 2010).
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However, it seems that the flexibilities allowed by the TRIPS Agreement, the Doha Declaration
and the Implementation Decision have done little to bring succour to the plight of a significant
proportion of the world population which continues to die on a daily basis from both communicable
and non-contagious diseases as a result of their inability to have access to medicine at affordable
costs.4
This article discusses the human right to health in the context of patent protection and access to
medicines. It examines the extent to which human rights considerations might be relevant in the
implementation of trade and IP agreements and whether a country can rely on its human rights
obligations in exploring the inherent flexibilities in the TRIPS Agreement. The article considers the
limitations in international human rights law, especially in relation to socioeconomic rights, that make
it difficult for the right to health to be a potent justification for derogation from trade or IP agreements.
It concludes by taking the view that while the right to health may be somewhat unenforceable in
international law, its close association with enforceable rights such as the right to life can be a
legitimate basis for making maximum use of the flexibilities in the IP system to protect public health.
The article takes the view that trade and IP agreements must be interpreted in a way that endeavours
as far as possible to resolve any seeming inconsistency with the right to health in favour of the latter.
It also argues that even where international human rights obligations are not directly enforceable by
national courts, such courts still have the obligation to apply their national laws in a way that gives
effect to their international and, where applicable, national human rights obligations.
GLOBAL HEALTH AND HEALTH INEQUITY
Global health has been defined as encompassing the “consideration of the health needs of the people
of the whole planet above the concerns of particular nations”.5 The determinants of health such as
pathogens, food, water and air are all issues that cut across borders, thereby making threats to health
largely transnational and an issue for global concern.6 Protecting the health of the world’s population
therefore requires significant international cooperation and global governance.7 The future of global
health looks quite dismal given that the countries most affected by diseases are not economically
buoyant enough to resolve the problem internally and the countries with the wherewithal seem
unwilling to commit significant resources to improving the standard of health outside their borders,
save where overwhelming humanitarian considerations exist.8 Indeed as noted by Gostin:
Most development assistance is driven by high-profile events that evoke public sympathy, such as a
natural disaster in the form of a hurricane, tsunami, drought, or famine; or an enduring catastrophe such
as the AIDS pandemic.9
Health inequity entails health discrepancies that are unfair and unnecessary, and they are not
inevitable.10 For instance, the chances of living to the age of five are low for the poor people of the
world in comparison with the wealthy.11 Populations in developed countries are mainly susceptible to
chronic non-communicable diseases because the available technologies are effective enough to
4 Rimmer M, “Race Against Time: The Export of Essential Medicines to Rwanda” (2008) 1 Public Health Ethics 12; Mitchell A
and Voon T, “The TRIPS Waiver as a Recognition of Public Health Concerns in the WTO” in Pogge T, Rimmer M and
Rubenstein K (eds), Incentives for Global Public Health: Patents Law and Access to Essential Medicines (Cambridge
University Press, Cambridge, 2010) pp 56, 72.
5 Merritt M, “Bioethics, Philosophy, and Global Health” (2007) 7 Yale Journal of Health Policy, Law & Ethics 273 at 274.
6 Gostin LO, “Meeting Basic Survival Needs of the World’s Least Healthy People: Towards a Framework on Global Health”
(2008) 96 George Town Law Journal 331 at 333.
7 See Fidler DP, “The Globalization of Public Health: Emerging Infectious Diseases and International Relations” (1997) 5
Indiana Journal of Global Legal Studies 11 at 17-18, 30-31.
8 Gostin, n 6 at 333-334.
9 Gostin, n 6 at 334.
10 Erdman JN, “Human Rights in Health Equity: Cervical Cancer and HPV Vaccines” (2009) 35 American Journal of Law &
Medicine 365 at 367.
11 See World Health Organization, World Health Statistics 2007 (2007), http://www.who.int/whosis/whostat2007.pdf viewed
13 April 2013.
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substantially control communicable diseases.12 But, people in poor countries are significantly affected
by many forms of contagious, avertible and curable diseases.13 To a large extent, there exists a general
consensus that global health disparities based on wealth are contrary to morality.14
As noted by Parento:
people are born with equal potential for healthy lives, yet the moment their lives begin, a confluence of
factors render some people immensely more likely than others to have the capability to lead healthy
lives.15
The incongruences in the ability of people to achieve the best attainable health standards
inexorably lead us to a significant social justice question. Does society owe a moral obligation to
reduce as much as possible the inequalities engendered by variables such as socioeconomic factors,
gender, race, education or even geographical location? Montesquieu argues that society takes away the
equality all people share at birth and that equality may only be recovered through the protection of the
law.16 It therefore appears that a compelling moral obligation exists on society to strive to ameliorate,
where possible, the disparities in the attainment of good health and this obligation, it would seem, is
best discharged through the instrumentality of the law. A range of legal instruments may be relevant to
the discharge of this obligation, yet there are others that, at least superficially, could enlarge rather than
ameliorate the disparities between rich and poor people in attaining good health. IP law is particularly
relevant here, because it seeks to protect the economic interest in goods directly accruing from human
ingenuity or creativity. With respect to pharmaceutical inventions, IP protection has the benefit of
providing an incentive to develop new medicines. But at the same time, it may have the unsavoury
effect of limiting the availability of such medicines only to people with the financial means to afford
them. This raises concerns on how best to strike a good balance between the protection of IP rights
and respect for human rights.
THE RIGHT TO HEALTH IN INTERNATIONAL LAW
The preamble to the World Health Organization (WHO) Constitution defines health as “a state of
complete physical, mental and social well-being and not merely the absence of disease or infirmity”.
There is a significant connection between health and human rights and this has led to wide
acknowledgment and recognition of a right to health. The connection between health and human rights
can be understood in the following terms: first, the influence of health policies on human rights;
secondly, the effect of human rights violation on health; and thirdly, the inexorable connection
between health and human rights.17 It therefore follows that health is intimately connected to human
rights such that the abuse of human rights in any form is likely to have some significant implications
for the health of the victim. In this regard, it has been argued that the effects of human rights abuses on
health are under-appreciated and that health can be affected by most if not all human rights violation.18
12 See Daar A et al, “Top Ten Biotechnologies for Improving Health in Developing Countries” (2002) 32 Nature Genetics 229
at 229-232; see also Singer P and Daar A, “Harnessing Genomics and Biotechnology To Improve Global Health Equity” (2001)
294 Science 87 at 87-89.
13 Adeyi O, Smith O and Robles S, Public Policy and the Challenge of Chronic Noncommunicable Diseases (World Bank,
Washington, 2007), http://siteresources.worldbank.org/INTPH/Resources/PublicPolicyandNCDsWorldBank2007FullReport.pdf
viewed 13 April 2013.
14 Ruger J, “Rethinking Equal Access: Agency, Quality, and Norms” (2007) 2 Global Public Health 78 at 88.
15 Parento EW, “Health Equity, Health People 2020, and Coercive Legal Mechanisms as Necessary for the Achievement of
Both” (2012) 58 Loyola Law Review 655 at 656.
16 de Montesquieu C, The Spirit of Laws (1750) Book VIII, § 3, http://www.constitution.org/cm/sol_08.htm viewed 13 April
2013.
17 Mann J et al, “Health and Human Rights” (1994) 1 Health and Human Rights 6; Walker EM, “The HIV/AIDS Pandemic and
Human Rights: A Continuum Approach” (2007) 19 Florida Journal of International Law 335 at 379.
18 Mann et al, n 17; Walker, n 17.
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While health as a human right has gained significant prominence over time, the agitation for the
universal recognition and implementation of human rights continues to be a contemporary issue.
Despite the combined efforts of governments, international organisations and non-governmental
organisations, a range of factors continue to militate against the attainment of good health standards all
over the world. Kirby has noted that in line with the current trend towards globalism, human rights
law should be used by judges to fill in the gaps in the legislation when ambiguities in the law are to be
resolved.19
Nonetheless, there remain a number of questions regarding conceptualisations of health as well as
evaluation of observance and general enforcement measures. Yamin notes that it is probably now
difficult to credibly argue that the right to health is too vague for enforcement at law or that it simply
embodies a set of political aspirations.20 The Committee on Economic, Social and Cultural Rights
(CESCR), in its General Comment No 14: The Right to the Highest Attainable Standard of Health,
stated that all health care facilities including medicines should be:
(a) available in adequate quantity;
(b) accessible to all without discrimination;
(c) acceptable in terms of compliance with medical ethics and custom; and
(d) scientifically appropriate and of good quality.
Indeed, the right to life, the time-honoured non-derogable human right can be interpreted to cover
the right to health and access to medicines.21 Access to medicines also has significant implications for
other human rights such as the right to the benefits of scientific progress, to education, to work and to
an adequate standard of living.22 In addition, the right to health entails economic accessibility in the
sense that health facilities, medicines and services should be accessible and affordable to all without
discrimination.23
The preamble to the WHO Constitution declares that the “enjoyment of highest attainable
standard of health is one of the fundamental rights of every human being without distinction of race,
religion, political belief, economic or social condition”.24 The Universal Declaration of Human Rights
(UDHR) states that “everyone has the right to a standard of living adequate for the well-being of
himself and of his family, including food, clothing, housing and medical care and necessary social
services”.25 In a similar vein, the International Covenant on Economic, Social and Cultural Rights
(ICESCR) provides that states shall recognise “the right of everyone to the enjoyment of the highest
attainable standard of physical and mental health”.26 Article 12(2)(d) of the ICESCR provides that
states should ensure “creation of conditions which would assure to all medical service and medical
19 Kirby M, “‘Judicial Activism’: Authority, Principle and Policy in the Judicial Method” (Speech delivered at the Hamlyn
Lectures, 55th Series, University of Cardiff, United Kingdom, 25 November 2003), http://www.hcourt.gov.au/assets/
publications/speeches/former-justices/kirbyj/kirbyj_25nov.html viewed 13 April 2013.
20 Yamin AE, “Not Just a Tragedy: Access to Medications as a Right under International Law” (2003) Boston University
International Law Journal 325 at 336.
21 Yamin, n 20 at 330.
22 Yamin, n 20 at 330.
23 Chuan-feng Wu, “Raising the Right to Health Concerns Within the Framework of International Intellectual Property Law”
(2010) Asian Journal of WTO & International Health Law & Policy 141.
24 Constitution of the World Health Organization, signed 22 July 1946 (entered into force 7 April 1948).
25 Universal Declaration of Human Rights, GA Res 217A (III), UN Doc A/810 (10 December 1948), Art 25.
26 International Covenant on Economic, Social and Cultural Rights, opened for signature 16 December 1966, 993 UNTS 3
(entered into force 3 January 1976), Art 12(1). Article 12(2) of the ICESCR further provides that states shall take necessary
steps for the: “provision for the reduction of the stillbirth rate and of infant mortality and for the healthy development of the
child; [t]he improvement of all aspects of environmental and industrial hygiene; [t]he prevention, treatment and control of
epidemic, endemic, occupational and other diseases; [t]he creation of conditions which would assure to all medical service and
medical attention in the event of sickness.” Other international conventions recognising the right to health are: the International
Convention on the Elimination of All Forms of Racial Discrimination, opened for signature 21 December 1965, 660 UNTS 195
(entered into force 17 September 1946), Art 5(e)(iv); the Convention on the Elimination of All Forms of Discrimination against
Women, GA Res 34/180, UN Doc A/34/46 (entered into force 3 September 1981), Arts 11(1)(f), 12 and 14(2)(b); the Convention
on the Rights of the Child, GA Res 44/25, UN Doc A/44/49 (entered into force 2 September 1990), Art 24; the International
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attention in the event of sickness”. This, it has been argued, raises a policy objective which imposes on
the government an obligation to provide access to, and also ensure the equitable distribution of health
facilities for all without discrimination, particularly in relation to vulnerable and marginalised
populations.27
The Declaration of Alma-Ata affirms the right to health and emphasises the need for the
international community to obliterate the gross inequality in the health status of people in developed
and developing countries as well as within countries.28 The right to health is recognised in many
regional instruments and not less than 115 national constitutions.29 At the domestic level, the right to
health is enshrined in over 60 national constitutions30 either as a fundamental right or a directive
principle. The entrenchment of human rights in the domestic laws of countries will make these rights
directly enforceable in the national courts of such countries, whereas the rights are not directly
enforceable in the municipal courts of countries that are yet to domesticate international human rights
law. The African Charter on Human and Peoples’ Rights also recognises the right of “every individual
to attain the highest state of physical and mental health” and enjoins all state parties to the Charter “to
protect the health of their people and to ensure that they receive medical attention when they are
sick”.31 The Protocol of San Salvador requires states to recognise health as a public good and to take
measures that safeguard the right to health.32
Article 24 of the Convention on the Rights of the Child also provides for the right to health. The
International Convention on the Elimination of All Forms of Racial Discrimination and the
Convention on the Elimination of All Forms of Discrimination against Women both require signatories
to eradicate race and gender-based discrimination in the provision of health services and public health
facilities. Access to medicines is also germane for people to be able to work, get a good education and
enjoy a good standard of living as well as social security.33 Article 15 of the ICESCR expressly
recognises the right of everyone “to enjoy the benefits of scientific progress and its applications”.
The American Convention on Human Rights is a document providing particularly for the
recognition and enforcement of civil and political rights. The American Convention does not contain
any explicit provision for the implementation of the right to health and other socioeconomic rights,
although it does provide in Art 26 that states should adopt measures:
with a view to achieving progressively, by legislation or other appropriate means, the full realization of
the rights implicit in the economic, social, educational, scientific, and cultural standards set forth in the
Charter of the Organization of American States as amended by the Protocol of Buenos Aires.
It is therefore correct to posit that there undoubtedly exists in international human rights law a
cognisable right to health. Its significance in international human rights law is beyond doubt. But its
enforceability is very much suspect and inchoate as illustrated below.
Convention on the Protection of Rights of All Migrant Workers and Members of their Families, GA Res 45/158, UN Doc
A/45/49 (entered into force 1 July 2003), Arts 28, 43(e) and 45(c); and the Convention on the Right of Persons with Disabilities,
GA Res 61/106, UN Doc A/61/49 (entered into force 3 May 2008), Art 25.
27 Erdman JN, “Human Rights in Health Equity: Cervical Cancer and HPV Vaccines” (2009) 35 American Journal of Law &
Medicine 365 at 379.
28 Declaration of Alma-Ata (International Conference on Primary Health Care, Alma-Ata, USSR, 6-12 September 1978), Art II.
29 See Office of the United Nations High Commissioner for Human Rights and World Health Organization, The Right to Health,
Fact Sheet No 31 (June 2008) p 10.
30 See Hunt P, The Right of Everyone to the Highest Attainable Standard of Physical and Mental Health: Report of the Special
Rapporteur, UN Doc E/CN.4/2003/58 (2003) p 20.
31 African Charter on Human and Peoples’ Rights, adopted 27 June 1981, 21 ILM 58 (entered into force 21 October 1986),
Art 16.
32 Additional Protocol to the American Convention on Human Rights in the Area of Economic, Social and Cultural Rights
“Protocol of San Salvador”, adopted 17 November 1988 (entered into force 16 November 1999), Art 10.
33 Yamin, n 20 at 341.
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ENFORCEABILITY OF THE RIGHT TO HEALTH
A fundamental right to health ordinarily entails something that cannot be guaranteed in a real sense –
perfect health.34 This is because perfect health is relative from person to person and nation to nation
and is therefore in real terms an indeterminate variable.35 Critics maintain that an argument for the
right to health is either misconceived or incapable of resulting in specific policy regulation beyond the
minimal acknowledgment of the right in question.36 While it would be misleading to refer to a
governmental responsibility to guarantee an individual’s good health, a case could be made for a right
to health protection which would consist of a right to health care and a right to live under healthy
circumstances.37 There is, however, still a large divide between the rights contained in the human
rights instruments and their implementation, especially in relation to social and economic rights.38
In view of the fact that treatment of life-threatening diseases forestalls death and morbidity, access
to medicines is considered an essential component of the right to life, the right to health and the right
to live in dignity.39 Rights to health are seen as a bundle of claims demanding positive actions on the
part of the government.40 However, since states are required by the ICESCR to promote the
enforcement of the right to health by “using the maximum available resources”, many states choose to
take advantage of the flexible language of the treaty to avoid any real obligation.41 Enforcement of the
right to health depends on a state’s fiscal and political circumstances, and as such the right is not
justiciable in many states, including India, Ghana, Nigeria, Pakistan and Ireland. Thus, judges in the
United States have refused to provide remedies for alleged violations of the ICESCR on the basis that
the indeterminacy of its principles makes it difficult for it to be capable of being judicially applied.42
However, implementing laws that are obviously inconsistent with the realisation of health rights
would amount to a violation of international law.43 In addition, failure to formulate health policies or
to implement laws that are connected to health would also be an omission that is inconsistent with the
right to health under international law.44 These arguments lend some credence to the position taken by
Meier and Yamin that international human rights provide a strong basis for advancing justice in health.
They contend that viewing “threats to public health as ‘rights violations’ offers international standards
by which to frame responsibilities and evaluate health policies and outcomes under law, shifting the
debate from political aspiration to legal responsibility”.45
34 Smith GP, “Human Rights and Bioethics: Formulating a Universal Right to Health, Health Care, or Health Protection” (2005)
38 Vanderbilt Journal of Transnational Law 1295 at 1315.
35 Smith, n 34.
36 Merritt, n 5 at 276.
37 Smith, n 34 at 1317.
38 Schachter O, “The Genesis of the Declaration: A Fresh Examination” (1999) 11 Pace International Law Review 51 at 57.
39 Novogrodsky N, “The Duty of Treatment: Human Rights and the HIV/AIDS Pandemic” (2009) 12 Yale Human Rights and
Development Law Journal 1 at 17.
40 Novogrodsky, n 39 at 19.
41 Craven M, The International Covenant on Economic, Social and Cultural Rights (Clarendon Press, Oxford, 1998) pp 16-22,
25-27, 113-114.
42 Flores v S Peru Copper Corp 414 F 3d 233 at 255 (2003). The United States has not ratified the ICESCR.
43 George E, “The Human Right to Health and HIV/AIDS: South Africa and South-South Cooperation to Reframe Global
Intellectual Property Principles and Promote Access to Essential Medicines” (2011) 18 Indiana Journal of Global Legal Studies
167 at 179.
44 Committee on Economic, Social and Cultural Rights, General Comment No 14: The Right to the Highest Attainable Standard
of Health, UN Doc E/C.12/2000/4 (11 August 2000).
45 Meier BM and Yamin AE, “Emerging Topics in Public Health Law and Policy: Right to Health Law Litigation and
HIV/AIDS Policy” (2011) 39 Journal of Law, Medicine and Ethics 81.
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Modibo Ocran of the Supreme Court of Ghana has postulated the following in a seminal paper on
the enforcement of socioeconomic rights in Africa:46
• socioeconomic rights should be seen as rights in the legal sense if they are enshrined in the
national constitution or incorporated in the municipal legal system; and
• actions based on socioeconomic rights could be enforceable in the courts even if all the resources
for their implementation are not immediately available as the notion of progressive realisation of
such rights puts a mandate on the government to implement the rights to the extent allowed by the
available resources.
The view has been expressed that for the right to health to be obligatory on governments, it must
possess conditions that are realistic for most states irrespective of their level of development and the
conditions must be such that would ensure that the provision of medicines is not seen as an obligation
most states cannot fulfil.47
The justiciability of human rights has been undermined by the absence of strong enforcement
mechanisms.48 Rights are certainly of no significance unless they are enforceable.49 The absence of
effective enforcement mechanisms may therefore be a reflection of states’ lack of enthusiasm for
human rights rather than inadvertence or inadequate foresight. Most human rights conventions provide
for some form of enforcement mechanisms such as an expert monitoring body with power to consider
petitions on human rights violation and present reports to a committee, a right of states against states
and in some cases an individual right of action may lie. These mechanisms, however, are not of
significant practical utility unlike the highly organised enforcement procedure for the TRIPS
Agreement under the WTO system. Although the CESCR is the body established to monitor the
implementation of the ICESCR, it has no power to sanction states which fail to meet the obligation
imposed on them by the treaty, and as such it lacks the power to compel the implementation of the
right to health.50 Multiple international investigative or adjudicatory bodies have been identified as
relevant to the enforcement of human rights.51
In the absence of an effective international framework for the enforcement of the right to health,
scholars have recommended the use of national adjudication52 and strong advocacy for compliance
with the right by non-governmental organisations (NGOs).53 Except where the right to health is
expressly provided for in domestic laws, individuals and communities cannot, generally speaking,
enforce the right to health in international law as they lack the locus standi to do so.
Another major problem with the implementation of the right to health is the fact that, along with
other rights in the ICESCR, it is subject to “progressive realization”,54 which takes into account the
46 Modibo Ocran T, “Socioeconomic Rights in the African Context: Problems with Concept and Enforcement” (2007) 5 Loyola
University Chicago International Law Review 1 at 13.
47 Modibo Ocran, n 46 at 735-736.
48 See, for example, Hafner-Burton EM, “Trading Human Rights: How Preferential Trade Agreements Influence Government
Repression” (2005)59(3) International Orgarnization 593 at 603.
49 See Jones JF, “Human Security and Social Development” (2004) 33 Denver Journal of International Law and Policy 92
at 97.
50 Torres MA, “The Human Right to Health, National Courts, and Access to HIV/AIDS Treatment: A Case Study from
Venezuela” (2002) 3 Chicago Journal of International Law 105 at 108.
51 Smith, n 34 at 1304.
52 See, for example, Yamin AE, “The Right to Health Under International Law and Its Relevance to the United States” (2005)
95 American Journal of Public Health 1156.
53 See Meier BM, “Employing Health Rights for Global Justice: The Promise of Public Health in Response to the Insalubrious
Ramifications of Globalization” (2006) 39 Cornell International Law Journal 711 at 737.
54 See, for example, International Covenant on Economic, Social and Cultural Rights, Art 2(1): “Each State Party to the present
Covenant undertakes to take steps … to the maximum of its available resources, with a view to achieving progressively the full
realization of the rights recognized in the present Covenant”; Convention on the Rights of the Child, Art 24(4): “States Parties
undertake to promote and encourage international co-operation with a view to achieving progressively the full realization of the
right recognized in the present article. In this regard, particular account shall be taken of the needs of developing countries.”
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resources at the country’s disposal to provide the necessary facilities for basic health care. Paucity of
funds is therefore always a good excuse for not meeting human rights obligations in view of the
treaty’s language.55 There is also to some extent the problem of ascertaining the exact contours of the
right to health and this may make it difficult to establish in clear-cut terms an infringement of the
right.56 It has been argued that international law appears to lack the framework for creating incentives,
legally binding obligations, funding or services to protect the world’s vulnerable population thereby
bringing about a situation whereby the global health problem remains a particularly intractable one.57
The enforcement of human rights is further made difficult by the fact that the human rights
conventions generally allow reservations and enforcement protocols are usually not mandatory. The
flexibility of the conditions for ascension to the conventions are, however, defensible as they make it
easier for many states to ratify a convention and this consequently enhances the creation of opinio
juris, which is needed to facilitate the emergence of customary international law that are evidenced by
that convention.58
In 2008, the General Assembly adopted the Optional Protocol to the International Covenant on
Economic, Social and Cultural Rights, which allows the CESCR to consider complaints by individuals
or by persons or organisations on their behalf.59 It would therefore appear that individuals and NGOs
acting on behalf of individuals who have suffered a violation of a right under the ICESCR can now
make special reports to the CESCR to ensure rights guaranteed under the Covenant are not violated
with impunity. Thus, people denied the right to health may now by themselves or through NGOs make
a case for the CESCR to intervene to give them succour, and countries receiving recommendations to
act in the interest of their citizens may rely on such recommendations in defending any trade dispute
that may arise out of the measure taken.
In sum, states are expected to take all reasonable steps to ensure their activities and policies are
not inconsistent with their human rights obligations. The argument has been advanced that in so far as
an action has been properly brought before the court, there is a duty on that court to develop a
manageable standard for the enforcement of human rights because socioeconomic rights are to be
considered as posing the same challenge as cutting-edge issues in other areas that the court will be
bound to resolve through a consideration of all the available authorities and resources at its disposal.60
It is therefore submitted that even though international conventions are not directly enforceable in
most national courts, such courts nonetheless are expected by the rules of statutory interpretation to
apply national laws where possible in a way that is consistent with the international obligation,
including international human rights obligations, of the country concerned. The duty of national courts
to adopt purposive interpretative rules where possible to give effect to human rights is explored below.
ENFORCEMENT IN NATIONAL COURTS
Some national courts are beginning to find the right to health justiciable in relation to access to
medicines. Thus, in the South African case of Minister of Health v Treatment Action Campaign (No 2)
[2002] 5 SA 721,61 the Constitutional Court discountenanced the government’s contention that it
55 Keener SR and Vasquez J, “A Life Worth Living: Enforcement of the Right to Health Through the Right to Life in the Inter
American Court of Human Rights” (2009) 40 Columbia Human Rights Law Review 595 at 599.
56 See also Tobin J, “Seeking to Persuade: A Constructive Approach to Human Rights Treaty Interpretation” (2010) 23 Harvard
Human Rights Journal 1.
57 Gostin, n 6 at 333.
58 Gostin, n 6 at 228-229.
59 Optional Protocol to the International Covenant on Economic, Social and Cultural Rights, GA Res A/RES/63/117
(10 December 2008).
60 See Soohoo C and Goldberg J, “The Full Realization of Our Rights: The Right to Health in State Constitutions” (2010) 60
Case Western Reserve Law Review 997 at 1009-1010.
61 See Heywood M, “Current Developments: Preventing Mother-to-Child Transmission in South Africa: Background, Strategies
and Outcomes of the Treatment Action Campaign Case Against the Minister of Health” (2003) 19 South African Journal of
Human Rights 278 at 285-286.
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lacked jurisdiction to adjudicate on socioeconomic rights claims and found the right to health as fully
justiciable. The court thus ordered the government to provide nevirapine (an HIV/AIDS drug capable
of preventing mother-to-child transmission) to pregnant women and newborn babies. The court further
mandated the government to develop a policy to make the drug available at public hospitals and
clinics. In India, the Indian Supreme Court has equally held that the right to life includes the right to
live with dignity and to possess basic necessities such as adequate nutrition, shelter and clothing.62
In Rodriguez v Caja Constarricense de Seguro Social (Supreme Court of Justice of Costa Rica,
Constitutional Chamber, Decision No 6096-97, 1997) and Alvarez v Caja Constarricense de Seguro
Social (Supreme Court of Justice of Costa Rica, Constitutional Chamber, Decision No 5934-97, 1997),
the Constitutional Chambers of the Costa Rican Supreme Court held that the state is bound to provide
AIDS treatment. The Venezuelan Supreme Court also reached a similar decision in Bermudez v
Ministerio de Sanidad y Asistencia Social (Supreme Court of Justice of Venezuela, Decision No 916,
1999). Similar decisions have equally been taken in countries such as Argentina,63 Chile,64 Ecuador,65
Mexico66 and Peru.67 Although the right to health is not particularly protected under the United States
Constitution, the United States courts have upheld the right of HIV-positive prisoners to access
medicines and health care facilities in a number of cases.68 Thus in Montgomery v Pinchak 294 F 3d
492 (2002), the United States Court of Appeals, Third Circuit, had to determine an appeal from a
summary judgment of the District Court against Montgomery, an inmate of the New Jersey State
correctional system. Montgomery had alleged, amongst other things, that he was denied access to his
HIV drugs and the right to a counsel in pursuing his case against the defendants. The Court of
Appeals, in vacating the District Court summary judgment, noted that Montgomery’s allegations
clearly established a case of intentional unresponsiveness to a serious medical need.
In a similar vein, in Brown v Johnson 387 F 3d 1344 (2004), the United States Court of Appeals,
11th Circuit, in overruling the lower court held that a prisoner who suffers from HIV and hepatitis and
alleges “the withdrawal of treatment in deliberate indifference to his serious medical needs” would
meet the threshold of “imminent danger of serious physical injury”, which is required as an exception
to the bar against a prisoner under 28 USC § 1915(g) from proceeding in forma pauperis where the
prisoner has already filed three frivolous lawsuits.
ENFORCEMENTS IN REGIONAL COURTS
The enforcement of the right to health at regional courts is discussed below in relation to
jurisprudence developed by the Inter-American Court of Human Rights, the African Court of Human
and Peoples’ Rights and the European Court of Human Rights.
Inter-American Court of Human Rights
The Inter-American Court of Human Rights, an independent judicial body of the Organisation of
American States, has developed a jurisprudence that allows the enforcement of the right to health
through the right to life. While the court has held that individual claims are not justiciable by their
62 Mullen v Union Territory of Delhi [1981] 2 SCR 516, cited in Yamin, n 20 at 335.
63 See UNAIDS and Canadian HIV/AIDS Legal Network, Courting Rights: Case Studies in Litigating the Human Rights of
People Living with AIDS, UNAIDS/06.01E (March 2006) pp 81-83.
64 See García Lopez v Southeast Metropolitan Health Service (Court of Appeals of Santiago, Petition for Protection,
No 2,614-99, 14 June 1999).
65 UNAIDS and Canadian HIV/AIDS Legal Network, n 63, pp 81-83.
66 See, for example, Ramirez v Instituto Mexicano del Seguro Social (Plenary Court of Supreme Court of Justice, Amparo
Decision 2231/97, April 2000).
67 See, for example, Meza-Garcia v Peru (Tribunal Constitutional (Constitutional Court) of Peru, Sentencia No 2945-2003-AA/
TC, April 2004).
68 See Montgomery v Pinchak 294 F 3d 492 (2002); Smith v Carpenter 316 F 3d 178 (2003); Brown v Johnson 387 F 3d 1344
at 1352 (2004).
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own force under Art 26 of the American Convention on Human Rights,69 the court has relied on Art 4
guaranteeing the right to life to secure health. Thus, in Villagran-Morales v Guatemala (Street
Children Case) (Inter-Am Ct HR (ser C) No 63, 19 November 1999), where the police murdered five
young men in an attempt to counter juvenile delinquency, the court held that the right to life includes
the right to access to conditions required for a dignified existence.
Particularly relevant to this discourse are Yakye Axa Indigenous Community v Paraguay
(Inter-Am Ct HR (ser C) No 125, 17 June 2005) and Sawhoyamaxa Indigenous Community v
Paraguay (Inter-Am Ct HR (ser C) No 146, 29 March 2006). In both cases, Indigenous groups were
displaced through the acquisition of their land by non-Indigenous populations.70 Due to their poor
standard of living, the communities brought legal action to reclaim their territories.71 While awaiting
the outcome of the legal action, the condition of the people deteriorated significantly resulting in
malnutrition, diseases and high infant deaths.72 In both cases, the Inter-American Court adopted a
liberal interpretation of the right to life in Art 4 of the American Convention.73 In the Yakye Axa case,
the court particularly noted that the state in protecting the right to life must generate living conditions
that are compatible with human dignity and not the other way round.74 The Inter-American Court
therefore ordered that the state must provide potable water for the people in sufficient quantity, provide
medical care and appropriate medicines to the community, and adequate treatment for worming of the
people.75 In Latin America, the Inter-American Commission on Human Rights has been noted to have
allowed precautionary measures with respect to over 400 claimant cases involving HIV-positive
people.76
The Inter-American Court’s incorporation of a positive duty of providing necessary facilities to
live a dignified life into the right to life – traditionally considered a negative right – is in line with the
right to health as expounded in General Comment No 14 and a means of securing health in the
Inter-American system.77 These decisions have adopted a liberal interpretation of the right to life and
the jurisprudence being developed can be helpful in safeguarding the health of people in developing
countries through the enforcement of the right to life, which is generally considered an enforceable
right. The right to life is therefore arguably wide enough to cover access to essential drugs.
African Court of Human and Peoples’ Rights
The African Charter on Human and Peoples’ Rights provides for the establishment of an African
Commission on Human and Peoples’ Rights.78 If a state party to the Charter reasonably believes there
has been a violation of the provisions of the Charter by another member state, it may notify that
member state of the violation,79 and if the issue is not resolved within three months, the matter may be
69 See Five Pensioners Case (Inter-Am Ct HR (ser C) No 98, 28 February 2003) at [88(e)].
70 Sawhoyamaxa Indigenous Community v Paraguay (Inter-Am Ct HR (ser C) No 146, 29 March 2006) at [73(1)]-[73(4)]; Yakye
Axa Indigenous Community v Paraguay (Inter-Am Ct HR (ser C) No 125, 17 June 2005) at [50.1]-[50.11].
71 Sawhoyamaxa Indigenous Community v Paraguay (Inter-Am Ct HR (ser C) No 146, 29 March 2006) at [73(6)]-[73(7)],
[73(17)]-[73(61)]; Yakye Axa Indigenous Community v Paraguay (Inter-Am Ct HR (ser C) No 125, 17 June 2005)
at [50.12]-[50.90].
72 Sawhoyamaxa Indigenous Community v Paraguay (Inter-Am Ct HR (ser C) No 146, 29 March 2006) at [73(67)]-[73(74)];
Yakye Axa Indigenous Community v Paraguay (Inter-Am Ct HR (ser C) No 125, 17 June 2005) at [50.93]-[50.98].
73 Sawhoyamaxa Indigenous Community v Paraguay (Inter-Am Ct HR (ser C) No 146, 29 March 2006) at [153].
74 Yakye Axa Indigenous Community v Paraguay (Inter-Am Ct HR (ser C) No 125, 17 June 2005) at [161]-[162].
75 Yakye Axa Indigenous Community v Paraguay (Inter-Am Ct HR (ser C) No 125, 17 June 2005) at [221].
76 See Melish T, “The Inter American Commission on Human Rights: Defending Social Rights Through Case-Based Petitions”
in Langford M (ed), Social Rights Jurisprudence: Emerging Trends in Comparative and International Law (Cambridge
University Press, Cambridge, 2009) p 369.
77 Keener and Vasquez, n 55 at 618-619.
78 African Charter on Human and Peoples’ Rights, Art 30.
79 African Charter on Human and Peoples’ Rights, Arts 47-53.
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taken before the Commission which may then launch an investigation and make findings.80 The
findings will be submitted to the Assembly of Heads of State and Government with recommendations
on the appropriate action to be taken.81 Public interest groups may also report cases of human rights
violation.82 The paradigm delineated for human rights enforcement under the African Charter was
described as basically “an intergovernmental arrangement for the invocation of the remedial process”
with its attendant high level of politicisation.83 The Charter is particularly relevant to this discourse
because, apart from the fact that it does provide that everyone “shall have the right to enjoy the best
attainable state of physical and mental health”,84 it equally provides for a number of health-related
rights including non-consensual treatment and medical experimentation.85
The Commission has found that the right to health guaranteed under the Charter obliges states to
provide medical care to prisoners.86 Also, failure to provide prisoners adequate food, blankets,
clothing and medical care have all been found to be in violation of the right to health as well as the
right to dignity.87 In a similar vein, the Commission found that Nigeria violated the right to health and
Art 24 by its oil exploration that led to significant environmental degradation and health deterioration
amongst the Ogoni people of the country.88
In 1998, the African Union (then Organization for African Unity) adopted the Protocol to the
African Charter on Human and People’s Rights on the Establishment of an African Court on Human
and People’s Rights.89 The Protocol entered into force on 1 January 2004. Article 5(3) of the Protocol
provides for the ability of individuals to have access to the African Court of Human and Peoples’
Rights in the following terms:
The Court may entitle relevant Non Governmental Organizations (NGOs) with observer status before
the Commission, and individuals to institute cases directly before it, in accordance with article 34(6) of
this Protocol.
However, by virtue of Art 34(6) of the Protocol, this provision is only operative where a state
party has deposited an instrument of declaration accepting the jurisdiction of the court to receive cases
under Art 5(3). In Femi Falana v African Union (African Court on Human and Peoples’ Rights,
Application No 001/2011, 26 June 2012), the applicant, having failed to successfully persuade his
government to make a declaration accepting the jurisdiction of the court over claims brought pursuant
to Art 5(3), approached the African Court with an application urging it to declare Art 34(6) void for
being inconsistent with the fair hearing and non-discrimination provisions of the African Charter. The
applicant sought this declaratory relief against the African Union as the representative body for its
53-member states. The African Court, however, declined jurisdiction to consider the claim on the basis
that the jurisdiction of the court is defined by the Protocol and as the African Union is not a party to
80 African Charter on Human and Peoples’ Rights, Art 48.
81 African Charter on Human and Peoples’ Rights, Arts 52-53.
82 African Charter on Human and Peoples’ Rights, Art 55.
83 Modibo Ocran, n 46 at 10.
84 African Charter on Human and Peoples’ Rights, Art 16(1).
85 African Charter on Human and Peoples’ Rights, Art 5.
86 Media Rights Agenda v Nigeria (Communication No 224/98), reported in 14th Annual Activity Report of the African Court for
Human and Peoples’ Rights (2000-2001).
87 See generally Malawi African Association v Mauritania (Communication No 51/91); Amnesty International v Mauritania
(Communication No 61/91); Diop v Mauritania (Communication No 98/93); Collectif de Veuves et Ayants-driot v Mauritania
(Communication Nos 164/97 and 196/97); Association Mauritanienne de Droits de l’Homme v Mauritania (Communication
No 210/98), all reported in 13th Annual Activity Report of the African Court on Human and Peoples’ Rights (1999-2000).
88 See Social and Economic Rights Action Center v Nigeria (African Commission on Human and Peoples’ Rights,
Communication No 155/96, 2001).
89 Organization of African Unity, Protocol to the African Charter on Human and Peoples’ Rights on the Establishment of an
African Court on Human and Peoples’ Rights, OAU Doc OAU/LEG/EXP/AFCHPR/PROT (9 June 1998).
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the Protocol, it cannot be sued under it. It therefore follows that the court cannot exercise jurisdiction
over individual claims emanating from a state that has made no declaration to accept the jurisdiction
of the court over cases brought by individuals.
European Court of Human Rights
The European Court of Human Rights has considered the issue of access to treatment in some
deportation cases involving HIV-positive refugee seekers. In D v United Kingdom (1997) 24 EHRR
423, the court restrained the deportation of an HIV-positive national of Saint Kitts on the ground that
the deportee would not be able to get treatment in the country of origin. The court found that allowing
the deportation would run afoul of Art 3 of the European Convention on Human Rights, which forbids
inhuman or degrading treatment. Similarly, in BB v France [1998] VI Eur Court HR 2595, a
Congolese man sought to remain in France so that he could receive treatment while serving his prison
term. The European Human Rights Commission referred the matter to the European Court of Human
Rights and France responded by quashing the conviction.
ECONOMIC AND PROPERTY RIGHTS AS HUMAN RIGHTS
It should be noted that the IP and human rights debate is not only about reconciling IP with human
rights, as IP rights are also human rights. The debate equally covers the question whether property
rights are as important or fundamental as the right to have access to medicines.
IP rights are well recognised as human rights in a number of international conventions, including
the UDHR and the ICESCR. Article 27 of the UDHR provides that a person has the right to the
protection of the moral and material interests resulting from any scientific, literary and artistic
production of which he or she is the author. Similarly, Art 15 of the ICESCR provides that a person
has the right to benefit from the protection of the moral and material interests resulting from any
scientific, literary and artistic production of which he or she is the author. Article 21(1) of the
American Convention on Human Rights provides for the right to property in the following terms:
Everyone has the right to the use and enjoyment of his property. The law may subordinate such use and
enjoyment to the interest of society.
Article 14 of the African Charter recognises the right to property and states that it “may only be
encroached upon in the interest of public need or in the general interest of the community and in
accordance with the provisions of appropriate laws”.
Article 1 of Protocol 1 to the European Convention on Human Rights gives some recognition to
property rights in the following terms:
Every natural or legal person is entitled to the peaceful enjoyment of his possessions. No one shall be
deprived of his possessions except in the public interest and subject to the conditions provided for by
law and by the general principles of international law.
Having shown that property rights are recognised as human rights in international law, the
question that arises from this is whether certain human rights are superior to others or, putting it in
more specific terms, whether the right to health is superior to IP rights? It has been argued that the
right to health is a basic right vital to a minimally adequate standard of living and therefore should
assume eminence over rights that are based on wants or desires.90 Schermers has argued that property
rights cannot be rightly described as fundamental rights except to the extent that they are needs-based
property rights that are essential to the exercise of rights that are really fundamental – like the right to
life.91 However, it is equally arguable that property rights are fundamental and vital to an adequate
standard of existence, although it is not easy to reach a consensus on this point.92 Drahos has noted:
90 Chandra R, “The Role of National Laws in Reconciling Constitutional Right to Health with TRIPS Obligations: An
Examination of the Glivec Patent Case in India” in Pogge et al, n 4, p 381.
91 Schermers HG, “The International Protection of the Right of Property” in Matscher F and Petzold H (eds), Protecting Human
Rights: The European Dimension (Carl Heymanns Verlag KG, Köln, 1988) pp 565-580.
92 See Cullet P, “Human Rights and Intellectual Property Protection in the TRIPS Era” (2007) 29 Human Rights Quarterly 403
at 405.
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Thinking about the right of property in the context of human rights reveals nicely the “paradox of
property”. At one level it is inconceivable that the development of human personality and the protection
of individual interests within a group can take place in the absence of property rules that guarantee the
stability of individual possession. Yet within the context of the social group no other rules require the
continuous adjustments that the rules of property do … It is for this reason that, when a general right of
property is recognised in a human rights instrument, it is made subject to some sweeping public interest
qualification.93
It follows that IP rights as private rights ought to give deference to public rights and public
interest qualifications in the event of conflict as to do otherwise will be to challenge the very basis
upon which all modern legal institutions are founded; that public interest shall always take precedence
over private interests that run contrary to it. Relying on the right to health to facilitate access to
medicines can produce real legal and institutional outcomes, and there are a number of cases where
health has actually been secured through IP rights.94
The significance of access to medicines to the right to health cannot be overemphasised. Haugen
notes that laying claim to social human rights “such as the right to food or the right to health, is about
the accessibility to important goods and resources”.95 Thus, given the paramount contribution of
health to the capabilities of people, health deserves a special moral significance that must be given
utmost priority by every government.96
ACCESS TO MEDICINES, THE RIGHT TO HEALTH AND PHARMACEUTICAL PATENTS
The right to health is wide enough to cover obligations to promote medical research and obligations to
ensure the distribution of the benefits of medical research especially in relation to medicines.97 The
view that patents are indispensable in relation to the promotion of medical research has been
challenged on a number of grounds. First, it is argued that pharmaceutical companies only invest in
products that would attract a viable market as not even patents would create a market where none
exists.98 Secondly, granting broad patents over a wide range of drugs to certain companies may result
in market dominance and anti-competitive practices that may stifle innovation.99 Thirdly, many
pharmaceutical patents are only for what are termed “me-too drugs” as they possess some slight
inventive step over the existing similar drugs and are not significantly innovative or novel in the real
sense.100
While access to medicines is a significant component of the right to health,101 about two billion
people have been reported to lack access to essential medicines.102 The Montreal Statement on the
Human Right to Essential Medicines was drawn in 2005 by a group of stakeholders from civil society
organisations, academic institutions, governments and international agencies following a workshop on
human rights and access to medicines. Although the Montreal Statement cannot be regarded as a legal
93 Drahos P, “Intellectual Property and Human Rights” (1999) 3 Intellectual Property Quarterly 349 at 360.
94 See Young KG, “Securing Health Through Rights” in Pogge et al, n 4.
95 Haugen HM, “Patents Rights and Human Rights: Exploring their Relationship” (2007) 10 Journal of World Intellectual
Property 97 at 98.
96 Puymbroeck RVV, “Coming to Grips with TRIPS: Conversion + Calculation” (2010) 38 Journal of Law, Medicines and
Ethics 520 at 527.
97 Vadi V, “Sapere Audi! Access to Knowledge as a Human Right and a Key Instrument of Development” (2008) 12
International Journal of Communications Law and Policy 345 at 358.
98 Vadi, n 97 at 359.
99 Grabowski H, “Patents, Innovation and Access to New Pharmaceuticals” (2002) 5 JIEL 849; Singham S, “Competition Policy
and the Stimulation of Innovation: TRIPS and the Interface Between Competition and Patent Protection in the Pharmaceutical
Industry” (2000) 26 Brooklyn Journal of International Law 363; Rai AK, “Fostering Cumulative Innovation in the
Biopharmaceutical Industry: The Role of Patents and Antitrust” (2001) 16 Berkeley Technology Law Journal 813.
100 Vadi, n 97 at 359.
101 George, n 43 at 168.
102 Grover A, Report of the Special Rapporteur on the Right of Everyone to the Enjoyment of the Highest Attainable Standard of
Physical and Mental Health, 11th Sess, UN Doc A/HRC/11/12 (31 March 2009) p 14.
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text in international law, a brief discussion of its provisions can be instructive. According to the
Montreal Statement, people lack access to medicines either as a result of the fact that research and
development do not focus on the ailments afflicting them, or due to inadequate health systems and the
unaffordable costs of existing medicines.103 The Montreal Statement notes that existing rules and
institutions are causing significant deprivations on an alarming scale and it recommends urgent
reforms that will ensure trade agreements, international institutions, IP laws, and national laws and
policies are designed in a way that will protect the right to essential medicines.104 The Montreal
Statement emphasises the need for international assistance and co-operation in human rights
fulfilment. Affluent states are enjoined to ensure fairer trade and investment, while contributing
equitably to international co-operation geared towards the complete realisation of the right to essential
medicines.105
There has been a significant debate on the extent to which IP protection conflicts with human
rights. The United Nations Sub-Commission on the Promotion and Protection of Human Rights noted
in 2000 that the Human Development Reports of 1999 and 2000 identify circumstances occasioned by
TRIPS that constitute contraventions of international human rights law.106 It further observes that
actual or potential conflicts exist between the TRIPS Agreement and access to patented
pharmaceuticals which may have serious impacts on the enjoyment of the right to health.107
The CESCR Statement on Human Rights and Intellectual Property states that both national and
international rules and policies on IP rights, including the TRIPS Agreement, must comply with
international human rights law.108 The CESCR goes further, stating that “any intellectual property
regime that makes it more difficult for a State party to comply with its core obligations in relation to
health, food, education, especially or with any other right set out in the Covenant is inconsistent with
the legally binding obligations of the State party”.109
The United Nations Human Rights Committee has interpreted the role of governments in
protecting the right to health as including obligations to lessen infant mortality, to improve life
expectancy, and to eradicate malnutrition and epidemics.110 The CESCR, in its comment on
Art 15(1)(c) of the ICESCR, which provides for the right to benefit from the protection of any
scientific, literary or artistic work of which one is an author, also notes that IP is a social product with
a social function. Further, it recognises the broad right of states to safeguard human rights in the
following terms.111
Therefore there is good support for the proposition that states should refrain from using IP rights,
including patents, in a way that derogates from the right of people to good health in international law.
103 For a full commentary on the Montreal Statement, see Pogge T, “Montreal Statement on the Human Right to Essential
Medicines” (2007 16 Cambridge Quarterly Healthcare Ethics 97 at 104.
104 Pogge, n 103 at 104.
105 Pogge, n 103 at 106.
106 Sub-Commission on the Promotion and Protection of Human Rights, The Realization of Economic, Social and Cultural
Rights: Intellectual Property Rights and Human Rights, UN Doc E/CN.4/Sub.2/RES/2000/7 (17 August 2000) at [2],
http://www.unhchr.ch/Huridocda/Huridoca.nsf/0/c462b62cf8a07b13c12569700046704e viewed 22 September 2012.
107 Sub-Commission on the Promotion and Protection of Human Rights, n 106 at [2].
108 See Committee on Economic, Social and Cultural Rights, Statement on Human Rights and Intellectual Property, UN Doc
E/C.12/2001/15 (14 December 2001) at [3].
109 Committee on Economic, Social and Cultural Rights, n 108 at [12].
110 United Nations Human Rights Committee, CCPR General Comment No 6: The Right to Life (30 April 1982), Art 5.
111 Committee on Economic, Social and Cultural Rights, General Comment No 17: The Right of Everyone to Benefit from the
Protection of the Moral and Material Interests Resulting from Any Scientific, Literary or Artistic Production of Which He Is the
Author, UN Doc E/C.12/GC/17 (12 January 2006), Art 15(1)(c).
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INTERFACE BETWEEN TRADE, IP AND ACCESS TO MEDICINES
There was a time when the connection between international trade and human rights was a very
controversial issue.112 There currently exists, however, a widely held view that trade and human rights
are well connected in ways that require some critical investigation.113
Thus, the United Nations Commission on Human Rights has noted that “achieving fair and
equitable trade liberalization by adopting human rights approaches to WTO rules will be an important
step in establishing a just international and social order”.114 The United Nations High Commissioner
for Human Rights has made a case for the assessment of the impacts of rules on human rights before
they are finalised.115 The CESCR has equally emphasised the point that WTO members are required to
comply with human rights obligations in multilateral trade negotiations.116
However, there are those who hold the view that international trade and IP both serve the common
purpose of promoting human rights. The argument is that the protection of IP in the world trade
regime would further enhance trade liberalisation,117 which is considered as very germane to wealth
maximisation.118 The corollary to this, as pointed out by the WTO Consultative Board, is that the
WTO trade regime will have effects that would traverse the field of commerce to the extent of yielding
outcomes that promote and enhance the human rights movement.119 This seems to reinforce the
prescient observation of Chimni that international human rights law and international economic law
would in the course of time “complement each other to create a global law of welfare”.120 He goes
further, however, to note that human rights law is not currently delivering on its promise because the
world economy is driven by states and forces who do not give pride of place to the travail and
language of rights particularly in relation to implementing economic, social and cultural rights.121
There is therefore a compelling need for the rules governing international trade to take full cognisance
of human right obligations and the public interest in safeguarding the health of people who need
access to life-saving medications.
Trade in high-priced pharmaceuticals may have the effect of denying to poorer countries any
affordable means of obtaining essential medicines for pressing health problems.122 There also seems to
be some documentary evidence to suggest that the drafters of international human rights documents
intended them to take precedence over other international agreements, including those related to
trade.123 This view is reinforced by the Charter of the United Nations, which accentuated the need to
respect human rights and dignity. The Marrakesh Agreement Establishing the World Trade
Organisation and the TRIPS Agreement also expressly recognise the need for trade arrangements to
promote human rights and general wellbeing. Thus parties to the Marrakesh Agreement recognise
112 Lang ATF, “Re-thinking Trade and Human Rights” (2007) 15 Tulane Journal of International and Comparative Law 335
at 336.
113 Lang, n 112 at 408.
114 See United Nations High Commissioner for Human Rights, Globalization and Its Impact on the Full Enjoyment of Human
Rights, UN Doc E/CN.4/2002/54 (15 January 2002) at [9].
115 United Nations High Commissioner for Human Rights, n 114 at [46].
116 CESCR, Substantive Issues Arising from the Implementation of the International Covenant on Economic, Social and
Cultural Rights – General Comment No 15: The Right to Water, UN Doc E/C.12/2002/11 (20 January 2003) at [35].
117 Narlikar A, The World Trade Organization: A Very Short Introduction (Oxford University Press, Oxford, 2005) pp 28-29.
118 Narlikar, n 117, p 2.
119 Sutherland P et al, The Future of the WTO: Addressing Institutional Challenges in the New Millennium (World Trade
Organization, Switzerland, 2004) p 10, http://www.wto.org/english/thewto_e/10anniv_e/future_wto_e.pdf viewed 14 April 2013.
120 Chimni BS, “A Just World Under Law: A View From the South” (2007) 22 American University International Law Review
199 at 206.
121 Chimni, n 120 at 206-207.
122 Lazzarini A, “Access to HIV Drugs: Are We Changing the Two World Paradigm?” (2002) 17 Connecticut Journal of
International Law 281 at 287.
123 Lazzarini, n 122 at 288.
Owoeye
(2014) 21 JLM 900914
“that their relations in the field of trade and economic endeavour should be conducted with a view to
raising standards of living” and in a way that will facilitate economic development. Similarly, Art 8.1
of the TRIPS Agreement provides:
Members may, in formulating or amending their laws and regulations, adopt measures necessary to
protect public health and nutrition, and to promote the public interest in sectors of vital importance to
their socio-economic and technological development, provided that such measures are consistent with
the provisions of this Agreement.
Article XX of the GATT allows states to adopt measures for the protection of human life or
health. However, the fact that human rights obligations are not expressly integrated into WTO
Agreements has resulted in a situation whereby human rights are seen as subordinate to trade
agreements.124 There is some support for the view that states can use the human rights argument to
justify the use of TRIPS flexibilities as provided for in Art 31 of TRIPS, and it is also argued that the
human rights debate may be used to justify the creation of additional grounds for compulsory
licensing having regards to the provision of paragraph 5 of the Doha Declaration.125 The argument is
therefore that the need for compliance with human rights obligations is part of the hierarchy of norms
to which WTO Agreements and Free Trade Agreements belong,126 as the whole body of WTO law is
no more than an integral part of the general body of public international law and is to that extent not
superior to any other specialised area of law.127 States in implementing international agreements
should therefore incorporate all available safeguards and flexibilities to ensure prevention, treatment
and access to medicines.128
International trade and IP protection must be pursued in a way that does not impede the general
standard of living of the world’s citizens. Trade laws with real likelihood of further widening the
north-south divide are in principle inconsistent with not only international human rights laws but also
the fundamental objectives of the WTO and the TRIPS Agreement. It is therefore submitted that the
protection of human rights is not inconsistent with the tenets and objectives of the WTO. Where there
exists a potential or real conflict between WTO Agreements and the right of people to reasonable
health care, the interpretation which best obliterate the inconsistency in favour of the protection of
peoples’ health should be adopted. Given the fact that the objective of the WTO is not to act at
variance with international human rights, it is further submitted that where there exists an
irreconcilable IP or trade agreement and the right to health, then the conflict should be resolved in so
far as possible in favour of the right to health and life as any contrary approach will not only be
immoral but will also amount to a grave affront to the fundamental principles and objectives of the
international legal order.
While it is true that TRIPS may have a significantly adverse effect on the domestic cost of
pharmaceutical products and health care in developing countries, there is also some evidence that a
weak IP system will reduce inventive activities.129 Patents may also have the undesirable effect of
stifling innovation, especially where a downstream developer of health care products has to make use
124 See Chapman AR, Approaching Intellectual Property as a Human Right: Obligations Related to Article 15(1)(c), UN Doc
E/C.12/2000/12 (3 October 2000).
125 Walker, n 17 at 361
126 Walker, n 17 at 367; see also Abbott FM, “The WTO Medicines Decision: World Pharmaceutical Trade and the Protection of
Public Health” (2005) 99 American Journal of International Law 317 at 356-357.
127 See Lamy P, “The Place and Role of the WTO (WTO Law) in the International Legal Order” (Address to the European
Society of International Law, Sorbonne, Paris, 19 May 2006), http://www.wto.org/english/news_e/sppl_e/sppl26_e.htm viewed
14 April 2013.
128 Walker, n 17 at 373
129 See Chaudhuri S, Golberg PK and Jia P, “Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case
Study of Quinolones in India” (2006) 96 Am Econ Rev 1477 at 1480-1481; Lanjouw JO and Cockburn IM, “New Pills for Poor
People? Empirical Evidence after GATT” (2001) 29 World Development 265.
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of different levels of innovation that are already protected by a proliferation of upstream patents.130
The conflict between patents and public health can be resolved by striking a fine balance between the
private right of inventors to the dividends of their invention and the public right of citizens to have
reasonable access to essential medicines. This balance is struck when patent protection does not
become an impediment to the reasonable and legitimate exercise of measures in the interest of public
health. It is thus submitted that where countries have taken reasonable measures that are legitimate
either under a WTO Agreement or the general body of public international law, then such measures
should always take precedence over any trade agreement to the contrary.
PUBLIC INTEREST MEASURES IN THE TRIPS AGREEMENT
Article 7 of the TRIPS Agreement provides that the protection and enforcement of IP rights should be
done in “a manner conducive to social and economic rights and to a balance of rights and obligations”.
In a similar vein, Art 8.1, set out above, provides for measures that are consistent with the TRIPS
Agreement to be adopted to protect public health and nutrition.
It has been argued that Art 8 does not empower members to adopt measures they consider useful
in the protection of public health and nutrition but only to adopt measures that are necessary to
achieve such ends.131 In fact, another commentator noted that the use of the word “necessary” rather
than “it considers necessary” in Art 73 inexorably suggests that the adoption of such measures is not
at the absolute discretion of the member invoking the provision but one that is subject to potential
review by the WTO in terms of validity.132
The experience of a number of developing countries over the years has shown that the flexibilities
allowed by the TRIPS Agreement are not really as flexible as one might want to assume. The position
is quite succinctly put by a commentator who notes that in practice, “trade negotiations and
applications have often been characterised by widespread disregard for human rights and the welfare
of the poorest and most vulnerable groups”.133 It is submitted on this point that the fact that Art 8
contains a proviso to the effect that the measures adopted must be “consistent with the provisions of
this Agreement” seems to take away any power to adopt measures in national interest that might
otherwise have been conferred by Art 8. The proviso may be interpreted as suggesting that the public
interest benefit in the Agreement is subject to the protection of the rights guaranteed in it and the
protection of IP rights should take precedence in the event of a conflict. It would appear the various
qualifications and ambiguities in the language of the TRIPS Agreement are a reflection of the highly
rigorous debates and deliberations that took place amongst the negotiators in the process of drafting
the treaty.
Indeed, one cannot but wonder whether Art 8 should be considered an example of “TRIPS
flexibility” or “TRIPS contradiction” in view of the fact that it does seem to take away in its proviso
any flexibility it might appear to have conferred.134 However, Yu has argued that a combined reading
of Arts 7 and 8 may help remove any potential inconsistency with the TRIPS Agreement thereby
giving effect to the objectives.135 In a similar vein, Correa noted that Art 7 should be understood in the
context of the preamble of TRIPS Agreement such that the balance of IP obligations and
130 See Reichman J, “Of Green Tulips and Legal Kudzu: Repackaging Rights in Subpatentable Innovation” (2000) 53 Vanderbilt
Law Review 1743; Madey v Duke University 307 F 3d 1351 (2002), where the court refused an experimental use defence in a
legal action against Duke University for patents infringement.
131 Yu PK, “The Objectives and Principles of the TRIPS Agreement” (2009) 46 Houston Law Review 979 at 1013.
132 Cann Jr WA, “On the Relationship Between Intellectual Property Rights and the Need of Less-Developed Countries for
Access to Pharmaceuticals: Creating a Legal Duty to Supply Under a Theory of Progressive Global Constitutionalism” (2004)
25 University of Pennsylvania Journal of International Economic Law 755 at 808.
133 Lazzarini, n 122 at 289-290
134 See also Yu, n 131 at 1014, describing the constraint as “eroding the pro-development aspect of Article 8”.
135 Yu, n 131 at 1014
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socioeconomic welfare would be taken into account.136 However, the fact remains that the flexibilities
available under TRIPS are more restrictive than the safeguard measure under Art XX of the GATT.
While in the case of the GATT, the need to protect human life or health may prevail over the general
rules of the agreement subject to the non-discrimination principle, the TRIPS flexibilities “are
circumscribed by various procedural and compensatory encumbrances” that make their use very
daunting.137 Given the fact that both the GATT and the TRIPS Agreement are part of the multilateral
trade agreements under the Marrakesh Agreement, both are subject to that Agreement in the event of
any inconsistency.138 However, the GATT and TRIPS Agreement are co-ordinate agreements in the
WTO hierarchy and to that extent neither can be binding on the other.139
The essence of the TRIPS public interest provision became a pertinent issue in the India case of
Novartis AG v Union of India (Supreme Court of India, Civil Appeal Nos 2706-2716 of 2013, 1 April
2013). Novartis obtained a United States patent for its anti-cancer drug Gleevec (imatinib) on 28 May
1996. At that time, no application was filed in India because Indian law did not provide for product
patents for pharmaceuticals. However, with the introduction of exclusive marketing rights under the
TRIPS regime, Novartis filed an application for the beta-crystalline form of imatinib mestylate in
India on 17 July 1998 and subsequently obtained an exclusive marketing right for this drug. On
25 January 2006, the Controller of Patents declined the patent application for this drug consequent
upon opposition initiated by competitors who were ready to make a generic version of the drug
available at significantly lower rates. Novartis challenged the Controller’s decision at the Madras High
Court, alleging non-compliance with TRIPS and standards in international law. The court upheld the
constitutionality of s 3(d) the Patents Act 1970 (India) and transferred the petition questioning the
order of the Controller to the Intellectual Property Appellate Board.140 The Appellate Board upheld the
decision of the High Court and Novartis further appealed to the Supreme Court.
On 1 April 2013, the Indian Supreme Court in a landmark decision held that Gleevec failed to
meet the patentability criteria for pharmaceutical products under Indian law.141 In coming to that
conclusion, the Supreme Court made reference to a number of fundamental issues that the court had to
take into account in interpreting the Indian Patents Act. One such issue is the human rights obligation
of the government under the Indian Constitution. The India Supreme Court, like the Appellate Board,
referred in its judgment to the following observation of the Madras High Court:
We have borne in mind the object which the amending Act wanted to achieve namely, to prevent
evergreening; to provide easy access to the citizens of the country to life saving drugs and to discharge
their constitutional obligation of providing good health care to its citizens.142
The Indian Supreme Court also noted the provision of Art 8 and other flexibilities in the TRIPS
Agreement that allow countries to implement TRIPS in a way that take the exigencies of local
circumstances into account.
It is apparent therefore that national courts can adopt a functional principle of interpretation that
will give effect to human rights. Even where access to medicines or the right to health is not a
recognised right in the national law of a given country, health and access to medicines can be
interpreted as germane to giving effect to the fundamental right to life and dignity of the human
person. Where no human rights whatsoever exist in the domestic framework of a given country, a
court may nonetheless apply the fundamental rights to life and dignity which are rights in customary
136 Correa CM, Trade Related Aspects of Intellectual Property Rights: A Commentary on the TRIPS Agreement (Oxford
University Press, 2007) p 104.
137 UNCTAD-ICTSD, Resource Book on TRIPS and Development (Cambridge University Press, 2005) p 132.
138 See Marrakesh Agreement Establishing the World Trade Organization, Art XVI(3).
139 Marrakesh Agreement Establishing the World Trade Organization, Arts II(2) and III(1).
140 Novartis AG v Union of India (Intellectual Property Appellate Board, Order No 100/2009, 26 June 2009),
http://www.ipab.tn.nic.in/Orders/100-2009.htm viewed 14 April 2013; Novartis AG v Union of India (Supreme Court of India,
Civil Appeal No 2706-2716 of 2013, 1 April 2013).
141 Novartis AG v Union of India (Supreme Court of India, Civil Appeal No 2706-2716 of 2013, 1 April 2013) at [195].
142 Novartis AG v Union of India (Supreme Court of India, Civil Appeal No 2706-2716 of 2013, 1 April 2013) at [18].
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international law to give effect to health on the basis that Parliament, except where a definite contrary
intention is disclosed, does not intend to contravene international law.
While the Doha Declaration and the Implementation Decision tend to address some of the
problems of access to medicines under the TRIPS regime, a number of issues still remain unresolved.
The WTO Appellate Body has equally expressed the view that “WTO Members have a right to
determine the level of protection of health that they consider appropriate in a given situation”.143
CONCLUSION
The human rights most susceptible to abuse by transnational corporations are economic, social and
cultural rights which in most cases are not actionable.144 Multinational companies are critical of any
measure taken to derogate from their IP rights and are ever ready to use their intimidating presence in
the global market to resist any act that does not give primacy to the protection of their IP interest.
Even the legitimate use of TRIPS flexibility has been challenged on multiple occasions.
So far, the major mode of censuring transnational corporations or imposing obligations on them
has been through market-based influence such as public campaigns, competitive practices,
well-informed investment tactics and other extra-legal strategies.145 There is a need for multinational
companies, especially in the pharmaceutical sector, to look beyond economic considerations and to be
more tolerant of measures taken to address public health at domestic levels.
In exploring the derogations and flexibility in the international IP system, countries can still rely
on their obligation to make adequate provision for the public health needs of their people under
international law. While the right to health may not be directly enforceable in international law, it is
nonetheless a well-recognised right in the international legal system and it thus provides a legitimate
basis for exploring current flexibilities in IP law like compulsory licensing, parallel trade and, to some
extent, minimum standards for patentability.
Human rights obligations of states should also be taken into account in interpreting trade
agreements in the WTO system. There is a strong emerging jurisprudence that supports the view that
international trade law is part of the general body of public international law and the WTO Appellate
Body has already held in the United States Gasoline case146 that WTO Agreements should not be
interpreted in clinical isolation from public international law. It therefore follows that the human rights
obligations of parties under public international law are to be taken into account in interpreting the
TRIPS Agreement and other trade agreements that may frustrate the ability of people to exercise their
rights to health. Where there is an apparent conflict between a trade agreement or an international IP
regime and international human rights law, the relevant adjudicating body should proceed on the
presumption that states do not intend to act in violation of their obligations under international human
rights law. To that extent, an interpretation that tends to be consistent with international human rights
obligation should be considered.
In Africa, the Protocol to the African Charter on Human and People’s Rights on the
Establishment of an African Court on Human and People’s Rights has made it possible for NGOs
acting on behalf of individuals and individuals whose rights have been violated or are likely to be
violated to approach the court for succour. This is a significant development in human rights and
social justice advocacy. It is now possible for individuals whose rights to health are in jeopardy to
143 WTO Appellate Body, European Communities – Measures Affecting Asbestos and Asbestos-Containing Products,
WT/DS135/AB/R (5 April 2001) at [168].
144 See Kinley D and Tadaki J, “From Talk to Walk: The Emergence of Human Rights Responsibilities for Corporations at
International Law” (2004) 44 Vanderbilt Journal of International Law 931 at 935.
145 See Fortanier F and Maher M, Foreign Direct Investment and Sustainable Development (OECD, 2001), http://www.oecd.org/
dataoecd/33/48/1906135.pdf viewed 14 April 2013; Steinhardt RG, “Corporate Responsibility and the International Law of
Human Rights: The New Lex Mercatoria” in Alston P (ed) Non-State Actors and Human Rights (Oxford University Press, 2005)
pp 180-187.
146 WTO Appellate Body, United States – Standards for Reformulated and Conventional Gasoline, WT/DS2/AB/R (29 April
1996) p 17.
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seek personal remedies through a regional court provided their countries have accepted the jurisdiction
of the court in that regard. Human rights jurisprudence is therefore germane to individuals who are
being denied reasonable access to life-saving drugs. Human rights may also provide a good defence
when trade sanctions and even legal actions are being used to restrain a state from legitimately
pursuing goals that may advance the socioeconomic rights of its citizens and their right to have access
to affordable drugs.
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